Literature DB >> 28028618

Characterization and genome analysis of novel bacteriophages infecting the opportunistic human pathogens Klebsiella oxytoca and K. pneumoniae.

Eun-Ah Park1, You-Tae Kim1, Jae-Hyun Cho1, Sangryeol Ryu2, Ju-Hoon Lee3.   

Abstract

Klebsiella is a genus of well-known opportunistic human pathogens that are associated with diabetes mellitus and chronic pulmonary obstruction; however, this pathogen is often resistant to multiple drugs. To control this pathogen, two Klebsiella-infecting phages, K. oxytoca phage PKO111 and K. pneumoniae phage PKP126, were isolated from a sewage sample. Analysis of their host range revealed that they infect K. pneumoniae and K. oxytoca, suggesting host specificity for members of the genus Klebsiella. Stability tests confirmed that the phages are stable under various temperature (4 to 60 °C) and pH (3 to 11) conditions. A challenge assay showed that PKO111 and PKP126 inhibit growth of their host strains by 2 log and 4 log, respectively. Complete genome sequencing of the phages revealed that their genome sizes are quite different (168,758 bp for PKO111 and 50,934 bp for PKP126). Their genome annotation results showed that they have no human virulence-related genes, an important safety consideration. In addition, no lysogen-formation gene cluster was detected in either phage genome, suggesting that they are both virulent phages in their bacterial hosts. Based on these results, PKO111 and PKP126 may be good candidates for development of biocontrol agents against members of the genus Klebsiella for therapeutic purposes. A comparative analysis of tail-associated gene clusters of PKO111 and PKP126 revealed relatively low homology, suggesting that they might differ in the way they recognize and infect their specific hosts.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28028618     DOI: 10.1007/s00705-016-3202-3

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  6 in total

1.  Characterization and formulation into solid dosage forms of a novel bacteriophage lytic against Klebsiella oxytoca.

Authors:  Teagan L Brown; Steve Petrovski; Dannielle Hoyle; Hiu Tat Chan; Peter Lock; Joseph Tucci
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

2.  The Novel Enterococcus Phage vB_EfaS_HEf13 Has Broad Lytic Activity Against Clinical Isolates of Enterococcus faecalis.

Authors:  Dongwook Lee; Jintaek Im; Hongjun Na; Sangryeol Ryu; Cheol-Heui Yun; Seung Hyun Han
Journal:  Front Microbiol       Date:  2019-12-17       Impact factor: 5.640

3.  Characteristics of a Bacteriophage, vB_Kox_ZX8, Isolated From Clinical Klebsiella oxytoca and Its Therapeutic Effect on Mice Bacteremia.

Authors:  Ping Li; Yangheng Zhang; Fuhua Yan; Xin Zhou
Journal:  Front Microbiol       Date:  2021-12-03       Impact factor: 5.640

4.  Efficacious antibacterial potency of novel bacteriophages against ESBL-producing Klebsiella pneumoniae isolated from burn wound infections.

Authors:  Ladan Rahimzadeh Torabi; Nafiseh Sadat Naghavi; Monir Doudi; Ramesh Monajemi
Journal:  Iran J Microbiol       Date:  2021-10

Review 5.  Bacteriophages of Klebsiella spp., their diversity and potential therapeutic uses.

Authors:  Warren P Herridge; Preetha Shibu; Jessica O'Shea; Thomas C Brook; Lesley Hoyles
Journal:  J Med Microbiol       Date:  2020-01-24       Impact factor: 2.472

6.  Isolation and Characterization of a Novel Lytic Bacteriophage against the K2 Capsule-Expressing Hypervirulent Klebsiella pneumoniae Strain 52145, and Identification of Its Functional Depolymerase.

Authors:  Botond Zsombor Pertics; Alysia Cox; Adrienn Nyúl; Nóra Szamek; Tamás Kovács; György Schneider
Journal:  Microorganisms       Date:  2021-03-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.